See more : Burford Capital Limited (BUR.L) Income Statement Analysis – Financial Results
Complete financial analysis of Supermax Corporation Berhad (7106.KL) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Supermax Corporation Berhad, a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- Umicore SA (UMICF) Income Statement Analysis – Financial Results
- Barclays PLC (BCY.DE) Income Statement Analysis – Financial Results
- Industrial and Commercial Bank of China Limited (1398.HK) Income Statement Analysis – Financial Results
- Sotherly Hotels Inc. (SOHO) Income Statement Analysis – Financial Results
- Woodbrook Group Holdings Inc. (WDBG) Income Statement Analysis – Financial Results
Supermax Corporation Berhad (7106.KL)
About Supermax Corporation Berhad
Supermax Corporation Berhad, an investment holding company, manufactures, distributes, and markets medical gloves and contact lenses in Malaysia. The company offers various types of natural rubber and nitrile latex gloves, as well as personal protective equipment. It is also involved in the trading, importing, and distribution of latex gloves; generation of biomass energy; marketing and distribution of healthcare products and medical devices; and property holding activities. The company sells its products to laboratories, pharmacists, hospitals, doctors, and surgeons under the Supermax, Aurelia, and Maxter brands. It also exports its products to approximately 165 countries, including the United States, the European Union, the Middle East, Asia, and the South Pacific countries. The company was founded in 1987 and is headquartered in Sungai Buloh, Malaysia.
Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 646.17M | 821.09M | 2.69B | 7.16B | 2.13B | 1.54B | 1.30B | 1.13B | 1.05B | 1.00B | 1.05B | 997.37M | 1.02B | 977.28M | 803.63M | 811.82M | 574.26M | 400.32M |
Cost of Revenue | 528.34M | 669.92M | 1.14B | 1.61B | 1.02B | 1.02B | 865.17M | 762.72M | 666.16M | 685.28M | 730.05M | 711.72M | 796.33M | 669.45M | 536.93M | 603.62M | 414.91M | 286.24M |
Gross Profit | 117.83M | 151.17M | 1.55B | 5.56B | 1.11B | 513.32M | 439.29M | 364.16M | 387.04M | 319.10M | 318.10M | 285.66M | 225.03M | 307.83M | 266.70M | 208.21M | 159.35M | 114.08M |
Gross Profit Ratio | 18.23% | 18.41% | 57.71% | 77.56% | 52.06% | 33.37% | 33.68% | 32.32% | 36.75% | 31.77% | 30.35% | 28.64% | 22.03% | 31.50% | 33.19% | 25.65% | 27.75% | 28.50% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 64.78K | 64.78K | 64.78K | 0.00 | 64.13K | 64.13K | 64.13K | 58.61M | 50.16M | 49.17M | 58.88M | 43.00M | 27.16M |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 0.00 | 408.42M | 446.32M | 623.80M | 405.12M | 64.78K | 64.78K | 64.78K | 245.55M | 64.13K | 64.13K | 64.13K | 58.61M | 50.16M | 49.17M | 58.88M | 43.00M | 27.16M |
Other Expenses | 292.10M | 0.00 | 410.70M | 541.59M | 417.70M | 326.67M | 269.34M | 256.37M | 906.47M | 192.39M | 179.02M | 162.91M | 76.62M | 102.20M | 85.82M | 79.26M | 61.36M | 46.45M |
Operating Expenses | 292.10M | 293.03M | 410.70M | 541.59M | 417.70M | 326.73M | 269.41M | 256.43M | 906.47M | 192.45M | 179.09M | 162.98M | 135.22M | 152.37M | 134.99M | 138.14M | 104.36M | 73.61M |
Cost & Expenses | 820.44M | 962.95M | 1.55B | 2.15B | 1.44B | 1.35B | 1.13B | 1.02B | 906.47M | 877.73M | 909.14M | 874.70M | 931.55M | 821.82M | 671.92M | 741.75M | 519.28M | 359.85M |
Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 34.68K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 5.23M | 7.22M | 5.71M | 8.11M | 17.08M | 19.71M | 13.98M | 11.06M | 7.35M | 8.17M | 7.63M | 8.75M | 12.55M | 13.91M | 22.26M | 20.34M | 15.28M | 12.68M |
Depreciation & Amortization | 68.41M | 85.35M | 73.85M | 68.76M | 61.66M | 45.00M | 41.77M | 41.22M | 32.58M | 27.94M | 26.69M | 24.36M | 24.09M | 26.04M | 31.94M | 28.85M | 19.92M | 12.95M |
EBITDA | -105.87M | -90.12M | 1.15B | 5.06B | 740.77M | 237.12M | 217.64M | 160.23M | 180.85M | 164.40M | 182.48M | 147.03M | 113.93M | 181.82M | 205.67M | 82.40M | 75.33M | 53.80M |
EBITDA Ratio | -16.38% | -7.71% | 44.75% | 71.45% | 36.21% | 15.42% | 16.69% | 14.23% | 15.16% | 16.37% | 17.41% | 17.09% | 14.56% | 22.86% | 25.57% | 14.50% | 16.25% | 18.14% |
Operating Income | -174.27M | -182.27M | 1.07B | 5.03B | 697.24M | 192.12M | 175.88M | 119.00M | 146.73M | 136.46M | 155.79M | 146.05M | 89.81M | 155.46M | 131.71M | 70.07M | 54.98M | 40.48M |
Operating Income Ratio | -26.97% | -22.20% | 39.64% | 70.18% | 32.71% | 12.49% | 13.48% | 10.56% | 13.93% | 13.59% | 14.86% | 14.64% | 8.79% | 15.91% | 16.39% | 8.63% | 9.57% | 10.11% |
Total Other Income/Expenses | -1.70M | -7.22M | -5.71M | -8.11M | -17.08M | -19.71M | -13.98M | -11.06M | -8.50M | -8.17M | -7.63M | -32.12M | -12.51M | -13.58M | -22.05M | -18.07M | -14.85M | -12.31M |
Income Before Tax | -175.97M | -189.49M | 1.06B | 5.02B | 680.16M | 172.41M | 161.89M | 107.94M | 152.36M | 128.29M | 148.16M | 137.31M | 112.13M | 183.84M | 151.47M | 52.00M | 58.55M | 47.34M |
Income Before Tax Ratio | -27.23% | -23.08% | 39.43% | 70.07% | 31.91% | 11.21% | 12.41% | 9.58% | 14.47% | 12.77% | 14.14% | 13.77% | 10.98% | 18.81% | 18.85% | 6.41% | 10.20% | 11.82% |
Income Tax Expense | 3.63M | -18.07M | 302.38M | 1.09B | 145.38M | 49.30M | 51.75M | 37.64M | 26.01M | 33.10M | 29.17M | 15.89M | 8.08M | 24.88M | 24.89M | 5.00M | 2.60M | 7.59M |
Net Income | -175.62M | -140.87M | 718.91M | 3.82B | 524.80M | 123.11M | 106.66M | 67.20M | 126.97M | 95.64M | 119.72M | 121.72M | 104.16M | 158.94M | 126.58M | 47.00M | 55.95M | 39.75M |
Net Income Ratio | -27.18% | -17.16% | 26.75% | 53.27% | 24.62% | 8.00% | 8.18% | 5.96% | 12.06% | 9.52% | 11.42% | 12.20% | 10.20% | 16.26% | 15.75% | 5.79% | 9.74% | 9.93% |
EPS | -0.07 | -0.05 | 0.27 | 1.42 | 0.10 | 0.04 | 0.04 | 0.02 | 0.04 | 0.03 | 0.04 | 0.04 | 0.04 | 0.06 | 0.06 | 0.02 | 0.03 | 0.01 |
EPS Diluted | -0.07 | -0.05 | 0.27 | 1.42 | 0.10 | 0.04 | 0.04 | 0.02 | 0.04 | 0.03 | 0.04 | 0.04 | 0.04 | 0.06 | 0.06 | 0.02 | 0.03 | 0.01 |
Weighted Avg Shares Out | 2.57B | 2.64B | 2.64B | 2.68B | 5.52B | 2.81B | 2.82B | 2.87B | 2.89B | 2.91B | 2.91B | 2.91B | 2.92B | 2.84B | 2.23B | 2.26B | 1.98B | 3.87B |
Weighted Avg Shares Out (Dil) | 2.57B | 2.64B | 2.64B | 2.68B | 5.52B | 2.81B | 2.83B | 2.87B | 2.92B | 2.91B | 2.91B | 2.91B | 2.92B | 2.84B | 2.25B | 2.26B | 2.01B | 3.90B |
Source: https://incomestatements.info
Category: Stock Reports